The Evolution of Ibogaine Treatment

Details


Date:	11/09/2021
Start Time:	9:10 am
End Time:	09:35

Boaz Wachtel

Founder & Executive Chairman, Ibogacine

Founder of ‘Ibogacine’ – an Ibogaine co (in formation) with 3 assets: partners with Cannasoul, (partly held by the Technion – (Israeli Inst. of Tech.) Brazil phase 2+3 clinical track & Ibo plantation …

David Meiri

Principal Investigator, Laboratory of Cancer Biology and Cannabinoid Research Facul

Associate Professor David (Dedi) Meiri comes from a highly diverse background. He holds an M.Sc. in biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. Dr. Meiri’s laboratory inv…

Deborah Mash, PhD

CEO & Founder, DemeRx

Deborah Mash is one of the world’s foremost experts on the hallucinogenic drug ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical stage drug development company advancing ibogaine and nor…

Talia Eisenberg

Founder, Beond

Talia Eisenberg is a serial entrepreneur focused on developing industry-leading consumer-facing products & services in the wellness and psychedelics industry. Founder of Ibogaine Research Institute, a…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.